Skip to main content
. 2020 Jan 13;15(1):e0226084. doi: 10.1371/journal.pone.0226084

Table 4. Random-effects meta-analysis according to DerSimonian and Laird and I^2.

n studies DerSimonian-Laird 95%-CI p-value I-squared 95%-CI
Pooled OR
male 6 0.32 (0.17 to 0.60) <0.001 48.8% (0.0 to 79.7)
Smoking (ever and past-smokers) 4 0.42 (0.23 to 0.76) 0.005 35.4% (0.0 to 77.5)
GGO (y/n) 3 § 32.05 (0.08 to 12654.94) 0.256 92.4% **
Honeycombing (y/n) 4 0.07 (0.02 to 0.30) <0.001 66.9% (0.0 to 88.2)
Consolidation y/n 3 14.34 (0.59 to 346.96) 0.101 78.5% (16.5 to 92.4)
Reticulation (y/n) 2 § 0.12* (0.01 to 1.10) 0.060 n.a. **
predominant GGO: GGO>(R+H) 2 3.68 (1.22 to 11.09) 0.021 0.0% **
predominant reticulation: (R+H)>GGO 2 0.15 (0.03 to 0.68) 0.014 67.3% **
H: H and/or R > G 2 0.06 (0.01 to 0.32) 0.001 0.0% **
Relative subpleural spearing (y/n) 3 16.33 (2.29 to 116.56) 0.005 67.4% (0.0 to 89.3)
peripheral predominance (outer 1/3) 6 0.21 (0.11 to 0.39) <0.001 16.2% (0.0 to 78.7)
central predominance/perbronchial (inner 2/3) 5 6.19 (2.43 to 15.75) <0.001 34.3% (0.0 to 75.2)
both inner outer 5 2.34 (1.07 to 5.11) 0.033 0.0% (0.0 to 79.2)
upper predominant distribution 3 § 0.53 (0.05 to 5.34) 0.592 0.0% **
lower (below carina/) 4 0.96 (0.28 to 3.36) 0.955 6.1% (0.0 to 85.6)
both upper lower 3 0.91 (0.23 to 3.63) 0.892 0.0% (0.0 to 89.6)
Pooled WMD
Age mean estimation 6 -4.37 (-6.98 to -1.77) 0.001 30.9% (0.0 to 73.5)
TOT disease extent (mean % of Lung volume) 6 -2.11 (-4.59 to 0.37) 0.095 0.0% (0.0 to 84.7)
GGO extent (mean % of Lung volume) 7 3.03 (1.31 to 4.75) 0.001 31.3% (0.0 to 73.7)
Honeycombing extent (mean % of Lung volume) 6 -3.86 (-6.65 to -1.06) 0.007 90.4% (78.6 to 95.7)
Consolidation extent (mean % of Lung volume) 7 1.79 (0.62 to 2.96) 0.003 58.9% (0.0 to 84.7)
Reticulation extent (mean % of Lung volume) 2 -0.28 (-2.13 to 1.56) 0.763 0.0% **
Emphysema extent (mean % of Lung volume) 2 -1.40 (-4.97 to 2.16) 0.440 71.5% **

* Single-study effect because one of the two studies were was excluded.

**No estimation possible because of, not enough too few studies.